Lemtrada®

Lemtrada® (alemtuzumab) is a monoclonal antibody that helps the body’s immune system by targeting and destroying certain cells helping to protect healthy cells from damage. Specifically it is a CD52-directed cytolytic monoclonal antibody for the treatment of Multiple Sclerosis (MS). While Lemtrada® does not cure MS it may help make relapses less frequent.

For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.

Lemtrada® Referral Form

WHAT IT TREATS:
MANUFACTURER:

Sanofi Genzyme

CLASS:
Biologics (CD52 monoclonal antibodies)
PRESCRIBED BY:

Neurologists

HOW ADMINISTERED:
IV infusion
FREQUENCY:

Daily for five days, then once a year

Length of infusion:
About four hours